当单个关节成为关键:炎症性关节炎中的单关节炎盲点
本文指出单关节炎在类风湿关节炎和银屑病关节炎中常被现有复合指数、试验纳入标准和指南算法低估,导致整体达标但单关节持续炎症的患者被忽视。作者认为单关节炎是决策问题而非测量干扰,呼吁开展索引关节表型分析、以关节为中心的结果评估及局部与系统治疗的比较研究。
要点
- 复合指数和达标治疗可数值稀释单个炎症关节的功能与预后权重。
- 整体达标但单关节持续炎症时,升级系统免疫抑制的获益增量常有限。
- 需开展索引关节表型、关节中心结局及局部与系统治疗比较研究。
核心结论
- 单关节炎不是测量干扰而是决策问题,当前测量系统、试验范式和治疗框架对其捕捉不足。
研究设计与样本
- 本文为观点文章(Viewpoint),非原始研究,未报告样本量或系统检索方法。
主要发现
- 单关节炎在类风湿关节炎和银屑病关节炎的起病时及达标治疗后残留滑膜炎中均可出现。
- 当代复合指数、试验纳入标准和指南算法基于多关节病构建,可数值稀释单个膝关节、踝关节或优势腕关节炎症的功能与预后权重。
- 整体疾病活动度可达预设治疗目标(如缓解或低疾病活动度),但患者因单关节持续炎症仍显著有症状或功能受限。
关键数值与推荐
- 原文未报告具体数值、阈值或推荐条款。
临床怎么用
- 当疾病负担为局灶性时,应审视常规升级系统免疫抑制的反射,因升级风险不随关节数减少而降低,而增量获益常随关节数减少而降低。
局限性
- 本文为观点文章,未提供原始数据或系统评价,结论基于作者论证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monoarthritis is a familiar-yet systematically under-theorised-scenario in rheumatoid arthritis and psoriatic arthritis, occurring both at onset and as residual synovitis that persists despite apparently successful treat-to-target care. Contemporary composite indexes, trial eligibility criteria, and guideline algorithms were built for polyarticular disease; as a result, these tools can numerically dilute the functional and prognostic weight of a single inflamed knee, ankle, or dominant wrist. This situation results in an uncomfortable paradox: overall disease activity can meet the predefined therapeutic target (eg, remission or low disease activity), while the patient remains substantially symptomatic or functionally limited because of persistent inflammation in a single joint. When the burden is focal, the usual reflex of escalating systemic immunosuppression deserves scrutiny, because the hazards of escalation do not shrink with joint count, whereas the incremental benefit often does. In this Viewpoint, we argue that monoarthritis is not merely a measurement nuisance but a decision problem. We examine why monoarthritis remains poorly captured by current measurement systems, trial paradigms, and treatment frameworks. We also highlight key research priorities to make monoarthritis visible again-both epidemiologically and methodologically-including index-joint phenotyping, joint-centred outcomes, and comparative evaluation of local versus systemic treatment strategies.
引用
- Ursini F, Ciaffi J, D'Angelo S, et al. When one joint matters: the monoarticular blind spot in inflammatory arthritis. Lancet Rheumatol. 2026. PMID: 42114539. doi:10.1016/S2665-9913(26)00080-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。